The efficacy of temozolomide combined with levetiracetam for glioblastoma (GBM) after surgery: a study protocol for a double-blinded and randomized controlled trial
出版年份 2022 全文链接
标题
The efficacy of temozolomide combined with levetiracetam for glioblastoma (GBM) after surgery: a study protocol for a double-blinded and randomized controlled trial
作者
关键词
-
出版物
Trials
Volume 23, Issue 1, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2022-03-29
DOI
10.1186/s13063-022-06168-1
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- How about Levetiracetam in Glioblastoma? An Institutional Experience and Meta-Analysis
- (2021) Ramazan Jabbarli et al. Cancers
- Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open‐label phase 2 study
- (2021) Kihwan Hwang et al. Cancer Medicine
- Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
- (2020) Tae Hoon Roh et al. Scientific Reports
- Progress Toward Long-Term Survivors of Glioblastoma
- (2019) J. Nathan Cantrell et al. MAYO CLINIC PROCEEDINGS
- Quantifying the prognostic significance in glioblastoma of seizure history at initial presentation: A systematic review and meta-analysis
- (2018) Victor M. Lu et al. CLINICAL NEUROLOGY AND NEUROSURGERY
- Levetiracetam enhances the temozolomide effect on glioblastoma stem cell proliferation and apoptosis
- (2018) Bianca Maria Scicchitano et al. Cancer Cell International
- Adult Glioblastoma
- (2017) Brian M. Alexander et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-inhibition effect of levetiracetam in combination with temozolomide in glioblastoma cells
- (2017) A. Marutani et al. Neurochemical Journal
- Improved Survival with Decreased Wait Time to Surgery in Glioblastoma Patients Presenting with Seizure
- (2017) Patrick M. Flanigan et al. NEUROSURGERY
- Patterns of care of brain tumor-related epilepsy. A cohort study done in Italian Epilepsy Center
- (2017) Marta Maschio et al. PLoS One
- The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
- (2016) David N. Louis et al. ACTA NEUROPATHOLOGICA
- Current and future strategies for treatment of glioma
- (2016) Nancy Ann Oberheim Bush et al. NEUROSURGICAL REVIEW
- Survival benefit of levetiracetam in patients treated with concomitant chemoradiotherapy and adjuvant chemotherapy with temozolomide for glioblastoma multiforme
- (2015) Young-Hoon Kim et al. CANCER
- The DNA damage/repair cascade in glioblastoma cell lines after chemotherapeutic agent treatment
- (2015) LAURA ANNOVAZZI et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Seizure Prognosis in Brain Tumors: New Insights and Evidence-Based Management
- (2014) Charles J. Vecht et al. ONCOLOGIST
- Enhanced MGMT expression contributes to temozolomide resistance in glioma stem-like cells
- (2013) Zhi-Kun Qiu et al. Chinese Journal of Cancer
- Grading dermatologic adverse events of cancer treatments: The Common Terminology Criteria for Adverse Events Version 4.0
- (2012) Alice P. Chen et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Cancer Statistics, 2010
- (2010) A. Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Levetiracetam enhances p53-mediated MGMT inhibition and sensitizes glioblastoma cells to temozolomide
- (2010) George C. Bobustuc et al. NEURO-ONCOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started